文献速递消化道出血消化内镜

左心室辅助装置植入后消化道出血的时间与出血解剖位置、表现及处理相关

Timing of Gastrointestinal Bleeding After Implantation of Left Ventricular Assist Devices Associates With Anatomic Location, Presentation, and Management.
PubMed 文献 · Clin Gastroenterol Hepatol · 2018-06-12

该回顾性研究纳入2008至2015年连续植入连续流左心室辅助装置的患者271例,其中59例(22%)发生消化道出血。左心室辅助装置植入当次住院期间发生的消化道出血以上、下消化道出血为主且表现更重,后期住院发生的出血则中消化道出血比例更高,且中消化道出血者均检出血管发育不良。

要点

  • 左心室辅助装置植入当次住院发生消化道出血者上、下消化道出血占86.7%,高于后续住院出血者的50.0%。
  • 中消化道出血者血管发育不良检出率为100%,上、下消化道出血者为48.5%。
  • 当次住院出血者住院时间24天、内镜前输血7单位,均高于后续住院出血者的11天和4单位。

核心结论

  • 连续流左心室辅助装置植入后消化道出血的时间与出血位置及严重程度相关。
  • 左心室辅助装置患者中消化道出血总体风险增加,但植入当次住院期间发生消化道出血者应首先接受上消化道内镜和结肠镜检查,因小肠血管发育不良形成时间不足。
  • 后期发生消化道出血者应早期评估中消化道出血。

研究设计与样本

  • 回顾性研究,连续纳入2008年至2015年接受连续流左心室辅助装置植入的患者271例。
  • 分析消化道出血的解剖位置、病因、住院时间、输血需求、内镜时间及30天内再入院。

主要发现

  • 271例患者中59例(22%)发生消化道出血。
  • 左心室辅助装置植入当次住院期间发生消化道出血者上、下消化道出血比例为86.7%,高于后续住院发生消化道出血者的50.0%(P = .013)。
  • 当次住院发生消化道出血者中消化道出血比例为0,后续住院发生消化道出血者为20.5%(P = .052)。
  • 当次住院发生消化道出血者显性出血比例为100%,后续住院发生消化道出血者为63.6%(P = .006)。
  • 当次住院发生消化道出血者住院时间24天、内镜前输血7单位,分别高于后续住院发生消化道出血者的11天和4单位(P < .001;P = .021)。

关键数值与推荐

  • 在检出出血病灶的患者中,中消化道出血者血管发育不良检出率为100%,上、下消化道出血者为48.5%(P < .001)。
  • 两组内镜时间(2天 vs 2.5天)和30天再入院率(6.7% vs 9.3%)无显著差异。

临床怎么用

  • 左心室辅助装置植入当次住院期间发生消化道出血者应首先接受上消化道内镜和结肠镜检查。
  • 左心室辅助装置植入后后期发生消化道出血者应早期评估中消化道出血。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Continuous-flow left ventricular assist devices (LVADs) for advanced heart failure have been associated with gastrointestinal bleeding (GIB). We examined the association between time of GIB after LVAD implantation and bleeding location (determined by endoscopy), etiology, and patient outcomes. METHODS: We performed a retrospective study of consecutive patients who underwent implantation of continuous-flow LVADs from 2008 through 2015. We analyzed data on anatomic location of GIB, etiology, length of hospital stay, transfusion requirement, time to endoscopy, and readmission to the hospital within 30 days (30-day readmission). RESULTS: GIB developed in 59 of the 271 patients (22%). Higher proportions of patients with GIB during their index hospitalization for LVAD implantation had upper or lower GIB (86.7%) than patients with GIB during a subsequent hospitalization (50.0%; P = .013). Patients with GIB during their index hospitalization also had lower rates of middle GIB (0 vs 20.5%; P = .052), higher rates of overt GIB (100% vs 63.6%; P = .006), longer hospital stays (24 days vs 11 days; P < .001), and more transfusions before endoscopy (7 units vs 4 units; P = .021) than patients with GIB during a subsequent hospitalization. There were no significant differences between groups in time to endoscopy (2 days vs 2.5 days) or 30-day readmission (6.7% vs 9.3%). Angiodysplasias were identified in 100% of patients with middle GIB compared to 48.5% of patients with upper or lower GIB (P < .001) in whom a bleeding lesion was identified. CONCLUSION: In a retrospective study of patients who underwent implantation of continuous-flow LVADs, we found that timing of GIB associates with the location and severity of bleeding. Although patients with LVADs have an overall increase in risk of middle GIB, patients with GIB during their index LVAD hospitalization should undergo initial evaluation by upper endoscopy and colonoscopy, due to insufficient time for development of small bowel angiodysplasias. Patients who later develop GIB should be evaluated early for middle GI bleeding.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Tabibian JH, Rhoades DP, Forde KA, et al. Timing of Gastrointestinal Bleeding After Implantation of Left Ventricular Assist Devices Associates With Anatomic Location, Presentation, and Management. Clin Gastroenterol Hepatol. 2018. PMID: 29906524. doi:10.1016/j.cgh.2018.05.056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。